← FDA Drug Approvals (Drugs@FDA)

ENFLONSIA

BLA · Biologics License Application · Sponsor: MERCK SHARP DOHME · Approved 2025-06-09

Drug application

FDA Application #

BLA761432

Application type

Biologics License Application

Brand name

ENFLONSIA

Generic name

CLESROVIMAB

Active ingredients

CLESROVIMAB-CFOR

Dosage form

INJECTION

Route

SOLUTION

Marketing status

Prescription

Sponsor

MERCK SHARP DOHME

Manufacturer

Merck Sharp & Dohme LLC

First approval

2025-06-09

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown